Trial Profile
Prospective study investigating safety and efficacy of Telaprevir-based triple therapy in patients with Hepatitis C after living donor liver transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Ciclosporin; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 30 Dec 2015 New trial record